Partners
Ajinomoto Bio-Pharma Services
Exhibition Partner
Ajinomoto Bio-Pharma Services is a global CDMO with sites in Belgium, India, the US, and Japan. We provide comprehensive one-stop services from process development to GMP manufacturing of pharmaceutical ingredients and intermediates for small, medium, and large molecules, as well as gene therapy. Our capabilities span pre-clinical to commercial stages, supported by proprietary platforms: AJIPHASE® (liquid-phase oligo/peptide), CORYNEX® (microbial protein/peptide expression), AJICAP® (site-specific conjugation for drug conjugates), and Fuel (AAV gene therapy).
ChemGenes
Exhibition Partner
Established in 1981, ChemGenes is the industry leader in manufacturing oligonucleotide synthesis reagents and has consistently provided the highest quality phosphoramidites and solid supports in the market. Our facility, just outside of Boston/Cambridge Massachusetts USA, is setup for bulk manufacturing of therapeutic grade phosphoramidite and solid support DNA/RNA synthesis products for GMP grade oligonucleotide manufacturing. ChemGenes carries the widest variety of modified phosphoramidites and supports currently used in oligonucleotide synthesis including Microarray Technology, Oligonucleotide Therapeutics, Oligonucleotide Based Probes and other areas of Nucleic Acid research.
In addition, ChemGenes is expanding its custom oligonucleotide synthesis department specializing in the manufacture of ASOs, siRNA, gRNA, gapmers, aptamers, DNA based probes, and superior quality beads for Single Cell mRNA sequencing applications using Drop-Seq, Slide-seq, and Seq-Well methods.
ChemGenes remains devoted to providing you with invaluable customer service and comprehensive technical support.
BioAgilytix
Exhibition Partner
As a leading global bioanalytical laboratory, we help our partners navigate the complex scientific and regulatory challenges inherent in the bioanalytical testing of new therapies to improve patients’ lives. Our experienced scientists deliver bioanalytical projects across all phases of drug development for pharmaceutical and biotechnology organizations of all types and sizes.
Leveraging the industry’s most complete set of capabilities and expert resources, our scientists working with your scientists to proactively anticipate assay challenges, and keep you on track. Our expertise, regulatory track record, focus on quality, and continuity of scientific oversight help avoid costly delays, ensuring your therapeutic advancements reach the market sooner.f